High level of soluble RAGE is associated with a greater risk of mortality in COVID‐19 patients treated with dexamethasone,50 and is considered to be a biomarker of COVID‐19 disease severity and indicator of the need for mechanical ventilation, acute respiratory distress syndrome and mortality.51 This evidence concerns the gene AGER and COVID-19.